Skip to content
Partnership for Safe Medicines
  • News
    • Diabetes & Weight-loss Injectables
    • Fake HIV Medications
    • PBMs
    • Botox / Botulism warning
    • Illegal Pill Presses
    • Fake Adderall
    • Poisonous cough syrup
    • Counterfeit Pill Crisis
  • Patients
    • Learn about Counterfeits and to Save Money Safely
    • Real Victims of Counterfeit Drugs
    • Talk to Your Family
    • HIV/HEPC Patients
    • Med spas
    • Mexican Pharmacies
    • Drug importation
  • Professionals
    • Pharmacists
    • Doctors
    • Law Enforcement
    • Prosecution Document Library
    • Research On Drug Safety
  • Policy
    • Publications
    • Pharmaceutical Border Security
    • Drug Importation
    • PBM under-reimbursement
    • Illegal Pill Presses
    • Affordability Boards (PDABs)
    • Alternative funding programs (AFPs)
    • Pharmacy-to-pharmacy marketplaces
    • FOIA-ed Materials
    • Events, briefings, and op-eds
  • About Us
    • Join Our Mailing List
    • Members
    • PSM Leadership
    • Press Releases
    • Contact Us
Document Tags: 2:22-cr-00049-RSM, PDL Cyendiv, PDL India, PDL Jardiance, PDL Keytruda, PDL Rajnish Kumar Jha, PDL Xovoltib, PDL extradition, PDL oncology drugs, judgment
Return to library

United States District Court
Western District of Washington

USA v Rajnish Kumar Jha

Judgment

Filed July 2025

Read the document.

R-Jha-judgment
© 2003-2023 Partnership for Safe Medicines
Click here to contact us.
Facebook Twitter Linkedin Youtube Instagram Email
Scroll To Top